thiazoles has been researched along with Adenocarcinoma, Basal Cell in 127 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (8.66) | 18.7374 |
| 1990's | 29 (22.83) | 18.2507 |
| 2000's | 53 (41.73) | 29.6817 |
| 2010's | 31 (24.41) | 24.3611 |
| 2020's | 3 (2.36) | 2.80 |
| Authors | Studies |
|---|---|
| Chin, CM; Scarim, CB | 1 |
| Chen, L; Gu, X; Han, F; Li, H; Li, M; Shang, L; Yang, Y; Zheng, M | 1 |
| Granados-Soler, JL; Hewicker-Trautwein, M; Klose, K; Murua Escobar, H; Nolte, I; Packeiser, EM | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Kawabata, Y; Kawabe, M; Kinomoto, T; Kuroda, H; Ogawa, S; Oishi, Y; Suguro, M | 1 |
| Fujitaka, K; Hamada, H; Hattori, N; Horimasu, Y; Iwamoto, H; Masuda, T; Miyamoto, S; Nakao, S; Nakashima, T; Sakamoto, S; Yamaguchi, K | 1 |
| Argano, M; Buracco, P; De Maria, R; Menzies, MPL; Rodlsberger, K | 1 |
| Kobayasi, S; Naresse, LE; Rodrigues, MA; Rodrigues, PA | 1 |
| Bruno, C; Carocci, A; Carrieri, A; Catalano, A; Cavalluzzi, MM; Franchini, C; Lentini, G; Viale, M | 1 |
| Bergman, M; Bokar, J; Brell, J; Chee, CE; Dowlati, A; Fu, P; Gibbons, J; Gudena, V; Krishnamurthi, S; Meropol, NJ; Nock, CJ; O'Brien, T; Reese, A; Saltzman, J; Teston, L; Wright, JJ | 1 |
| Brunner, AM; Costa, DB; Garcia, E; Hammerman, PS; Heist, RS; Johnson, BE; Lindeman, NI; Oxnard, GR; Sholl, LM | 1 |
| Chang, CC; Chang, JM; Chuang, SH; Huang, JJ; Huang, LY; Kao, KJ; Lau, JY; Lee, YS; Lin, HS; Liu, CW; Tsai, PY; Tsai, YJ | 1 |
| George, TJ; Liu, C; Trevino, JG | 1 |
| Chen, HJ; Hsu, JL; Huang, CC; Hung, MC; Kuo, TT; Kuok, QY; Lai, LC; Lin, CY; Lu, TP; Sher, YP; Sung, SY; Tseng, GC | 1 |
| Gao, Y; Hao, F; Jiang, G; Li, Q; Liu, Z; Pan, Y; Wang, E; Xie, C; Xie, L; Zhang, X | 1 |
| Jaggi, M; Joshi, V; Negi, LM; Ronodip, K; Talegaonkar, S | 1 |
| Chen, C; Du, Q; Gao, W; Hou, L; Hui, Z; Su, B; Sun, Y; Xie, H; Xu, Y; Zhang, P; Zhou, X | 1 |
| Chang, HT; Hsiao, ES; Liao, PC; Sun, JL; Wang, CC; Wu, HY; Wu, WS; Yang, TH | 1 |
| Kolodziej, H; Lucas, IK | 1 |
| Han, MH; Jung, M; Lee, S; Min, D | 1 |
| Liu, YH; Zhu, WL | 1 |
| Gou, SM; Huang, P; Liu, T; Wang, CY; Wu, HS; Xiong, JX | 1 |
| Batlle, A; Battah, S; Casas, A; Di Venosa, G; Dobbin, P; Fukuda, H; MacRobert, AJ; Rodriguez, L | 1 |
| Chan, SW; Chung, MK; Guo, DJ; Leung, TY; Li, WY; Yu, PH | 1 |
| Athanasiou, AE; Eliades, G; Eliades, T; Kletsas, D; Pratsinis, H | 1 |
| Araujo, JC; Corn, P; Darnay, BG; Lee, F; Logothetis, CJ; Parikh, NU; Poblenz, A; Starbuck, MW; Thompson, JT | 1 |
| An, QX; Chen, R; Huang, XF; Mu, SJ; Wu, DC; Xia, AJ; Zhang, XQ | 1 |
| Li, SH; Pang, B; Qian, XL; Shi, QG; Wang, J; Wang, LL; Wu, RQ; Xie, BX; Yu, L; Zhang, H; Zhou, JG | 1 |
| Abrantes, AM; Beja, AM; Botelho, MF; Brito, AF; Laranjo, M; Paixão, JA; Pinho E Melo, TM; Silva, MR; Soares, MI | 1 |
| Chen, Y; Ge, W; He, D; Hu, K; Jie, F; Li, C; Xu, X; Zhang, J; Zhang, L; Zhang, Y; Zhao, Z; Zheng, Y | 1 |
| Azzoli, CG; Ginsberg, MS; Johnson, ML; Kris, MG; Miller, VA; Pao, W; Riely, GJ; Rizvi, NA; Sima, CS | 1 |
| Allen, JE; Brown, JM; Daniel, CJ; Dicker, DT; Dolloff, NG; Dorsey, JF; El-Deiry, WS; Furth, EE; Hart, LS; Jee, DI; Klein, PS; Kuribayashi, K; Liu, JJ; Liu, YY; Mayes, PA; Sears, RC | 1 |
| Hossain, MZ; Kleve, MG | 1 |
| Aubourg, A; Chaigne, B; de Muret, A; Jonville-Bera, AP; Lagier, L; Machet, L; Samimi, M | 1 |
| Liu, J; Mao, JW; Mei, WJ; Sun, DD; Wang, WZ | 1 |
| Dogan, AL; Esendagli, G; Gönül, N; Guc, D; Hasçiçek, C; Şengel-Türk, CT | 1 |
| Braun, RD; Chunta, JL; Vistisen, KS; Yazdi, Z | 1 |
| Fedoročko, P; Jendželovský, R; Koval, J; Mikeš, J; Papčová, Z; Plšíková, J | 1 |
| Graves, P; Zeng, Y; Zhang, X | 1 |
| Decker, M; Eckel, F; Frank, R; Helmberger, H; Lersch, C; Lippl, F; Neverve, J; Schulte-Frohlinde, E; Schusdziarra, V; Schwaiger, M; Weber, W | 1 |
| Ethridge, RT; Evers, BM; Hashimoto, K | 1 |
| Batlle, A; Casas, A; Di Venosa, G; Fukuda, H | 1 |
| Iyengar, S; Peehl, DM; Roberts, RL; Shappell, SB; Xu, Y | 1 |
| Burgermeister, E; Liscovitch, M; Tencer, L | 1 |
| Dono, K; Hayashi, N; Hiraoka, N; Monden, M; Nagano, H; Nakamori, S; Okami, J; Sakon, M; Tsujie, M; Umeshita, K | 1 |
| Bianchi, A; Caraci, F; Chiechio, S; Chisari, M; Frasca, G; Pinto, A; Salomone, S; Sortino, MA | 1 |
| Fan, W; Wu, X; Xu, S; Zhou, Y | 1 |
| Hattori, T; Kumagai, H; Miwa, K; Mukaisho, K; Sugihara, H; Yamamoto, G | 1 |
| Beraldi, E; English, JC; Evans, K; Fazli, L; Gleave, ME; July, LV; So, A | 1 |
| Oberley, TD; Webber, MM; Yan, T; Zhong, W | 1 |
| Chung, LW; Hsieh, CL; Jin, F; Kuo, CJ; Xie, Z | 1 |
| Andreescu, S; McGee, DW; Sadik, OA | 1 |
| Chen, SZ; Jiang, M; Zhen, YS | 1 |
| Abderrahmani, A; Haefliger, JA; Leisinger, HJ; Martin, D; Tawadros, T; Waeber, G | 1 |
| Al-Wadei, N; Hussein, A; Schuller, HM; Takahashi, T | 1 |
| Shih, PH; Yeh, CT; Yen, GC | 1 |
| Debeir, O; Decaestecker, C; Hayot, C; Kiss, R; Van Damme, M; Van Ham, P | 1 |
| Hattori, T; Mukaisho, K; Shimomura, A; Sugihara, H; Suo, M | 1 |
| Abbruzzese, JL; Baker, CH; Donato, NJ; Gallick, GE; Hong, DS; Lee, FY; Lesslie, DP; Parikh, NU; Summy, JM; Trevino, JG | 1 |
| Karasek, M; Kunert-Radek, J; Lawnicka, H; Pawlikowski, M; Winczyk, K | 1 |
| Büchler, MW; Ceyhan, GO; Erkan, M; Friess, H; Giese, NA; Giese, T; Kerscher, AG; Wente, MN | 1 |
| Cekanova, M; Fedorocko, P; Majidi, M; Masi, T; Plummer, HK; Schuller, HM | 1 |
| Bilim, VN; Billadeau, DD; Chari, ST; Fernandez-Zapico, ME; Ougolkov, AV; Smyrk, TC | 1 |
| Cheung, M; Fukuyama, T; Han, FS; Osajima, H; Tokuyama, H | 1 |
| Cho, SJ; Jung, HC; Kim, JS; Kim, N; Song, IS | 1 |
| Huang, Z; Lei, X; Liao, D; Tang, S; Zhong, M; Zhu, B | 1 |
| Kobayashi, M; Natsume, T; Watanabe, J | 1 |
| Auzenne, E; Evans, R; Farquhar, D; Ghosh, SC; Hail, N; Klostergaard, J; Leroux, ME; McDonnell, T; Spohn, W | 1 |
| Barrett, YC; Blackwood-Chirchir, A; Camuso, A; Fager, K; Galbraith, S; Lee, FY; Luo, FR; McGlinchey, K; Palme, H; Smykla, R; Wen, ML; Wild, R; Yang, Z | 1 |
| Belkhiri, A; Castells, A; Correa, P; Dar, AA; El-Rifai, W; Koyama, T; Pera, M; Piazuelo, MB; Washington, K; Zaika, A | 1 |
| Wang, ZJ; Zhang, Q; Zhao, XH | 1 |
| Choi, JE; Duong, HQ; Han, SI; Kang, HS; Kim, CH; Kim, SM; Lim, SC | 1 |
| Hisatsugu, T; Katano, M; Kubota, E; Matsuo, T; Nagumo, F; Tadano, J | 1 |
| Alton, P; Elgie, A; Hill, JG; Sargent, J; Taylor, CG; Wilson, J | 1 |
| Darro, F; Etievant, C; Kiss, R; Kruczynski, A; Martinez, J; Pasteels, JL | 1 |
| Furukawa, T; Ishibiki, K; Kase, S; Kodaira, S; Kubota, T; Takahara, T; Takeuchi, T; Teramoto, T; Watanabe, M; Yamaguchi, H | 1 |
| Gemba, K; Kiura, K; Matsumura, T; Moritaka, T; Ohnoshi, T; Segawa, Y; Shibayama, T; Tabata, M; Takigawa, N; Ueoka, H | 1 |
| Eliason, JF; Kaufmann, F; Tanaka, T; Tsukaguchi, T | 1 |
| Bérubé, G; Ford, CH; Gallant, M; Lau, A | 1 |
| Tan, BK; Wong, KT | 1 |
| De Clercq, E; Hashimoto, K; Igarashi, A; Kodama, E; Mori, S; Shigeta, S; Suzuki, T | 1 |
| Cendan, JC; Copeland, EM; Lind, DS; Souba, WW | 1 |
| Bando, T; Fujimura, M; Kasahara, K; Matsuda, T; Shibata, K; Shirasaki, H | 1 |
| Dämmrich, J; Hensel, F; Meyer-Bahlburg, A; Müller-Hermelink, HK; Ribbert, H; Ufken-Gaul, T; Vollmers, HP; von Korff, M | 1 |
| Bai, F; Hara, N; Kawasaki, M; Mizuno, K; Nakanishi, Y; Pei, XH; Takayama, K; Tsuruta, N | 1 |
| Fujimura, S; Kobayashi, S; Okada, S; Yoshida, H | 1 |
| Asou, H; Elstner, E; Heber, D; Koeffler, HP; Koshizuka, K; Müller, C; Park, D; Said, JW; Shintaku, P; Williamson, EA | 1 |
| Alton, PA; Elgie, AW; Hill, JG; Reid, FD; Sargent, JM; Taylor, CG | 1 |
| Auwerx, J; Briggs, M; Chen, I; Desreumaux, P; Fruchart, JC; Geboes, K; Heyman, R; Lefebvre, AM; Najib, J | 1 |
| Chen, LB; DeAngelo, DJ; Fletcher, C; Holden, SA; Jones, D; King, FJ; Mueller, E; Partridge, JB; Sarraf, P; Singer, S; Spiegelman, BM | 1 |
| Alvarez, JG; Baird, SM; Evans, RM; Ming, UT; Nelson, MC; Saez, E; Thomazy, VA; Tontonoz, P | 1 |
| Fujishita, T; Kobayashi, M; Mizushima, Y; Oosaki, R; Sassa, K | 1 |
| Fujita, M; Higashino, K; Tsuchida, T | 1 |
| Baldwin, W; Barrett, JC; Biermann, J; Jayadev, S; Murphy, E; Petranka, J | 1 |
| Hotta, T; Ishimoto, K; Iwahashi, M; Matsuda, K; Tanaka, H; Tani, M; Tanimura, H; Tsunoda, T; Yamaue, H | 1 |
| Hussey, HJ; Tisdale, MJ | 1 |
| Carey, M; Hisatake, JI; Holden, S; Ikezoe, T; Koeffler, HP; Tomoyasu, S | 1 |
| Kohgo, Y; Motomura, W; Obara, T; Okumura, T; Takahashi, N | 1 |
| Elnemr, A; Fushida, S; Iwata, K; Kayahara, M; Kitagawa, H; Miwa, K; Ninomia, I; Nishimura, G; Ohta, T; Terada, T; Yamamoto, M | 1 |
| Aikou, T; Takao, S; Tsubouchi, H | 1 |
| Montaner, B; Pérez-Tomás, R | 1 |
| Jiang, ZF; Liu, XQ; Liu, XW; Paradiso, A; Song, ST; Tang, ZM; Xu, JM; Zhang, J | 1 |
| Baek, SJ; Eling, TE; Hsi, LC; Ikawa, H; Kameda, H; Kamitani, H; Nixon, JB | 1 |
| Mahyar-Roemer, M; Roemer, K | 1 |
| Arakawa, T; Fujiwara, Y; Hasuma, T; Higuchi, K; Otani, S; Takashima, T; Yano, Y | 1 |
| Cao, WM; Imachi, H; Ishida, T; Momoi, A; Murao, K; Sato, M; Takahara, J | 1 |
| Chappatte, O; Elgie, AW; Hill, JG; Lewandowicz, GM; Sargent, JM; Taylor, CG; Williamson, CJ | 1 |
| Kawa, S; Kiyosawa, K; Nakayama, K; Nikaido, T; Unno, H; Usuda, N | 1 |
| Chang, TH; Szabo, E | 1 |
| Dixon, B; Furr, BJ; Jordan, VC; Prestwich, G | 1 |
| Azzi, S; Guillemin, F; Lignon, D; Merlin, JL; Ramacci, C; Zeghari, N | 1 |
| Isshiki, K; Kubota, H; Nishimoto, F; Usuda, M; Yamashoji, S | 1 |
| Hayashihara, K; Hino, M; Kobayashi, K; Nakahiro, K; Niitani, H; Takemoto, T; Wasai, S | 1 |
| Berger, MR; Galeano, A; Keppler, BK | 1 |
| Isobe, K; Nakashima, I; Satta, T; Takagi, H; Yamauchi, M | 1 |
| Furukawa, T; Ishibiki, K; Kase, S; Kitajima, M; Kodaira, S; Kubota, T; Kuo, TH; Nishibori, H; Saikawa, Y; Watanabe, M | 1 |
| Fliri, AF; Gallaschun, RJ; Goodwin, P; Grissom, M; Mangano, FM; McNiff, PA; Olson, TH; Schnur, RC; Singleton, DH; Sloan, DE | 1 |
| Black, J; Ip, MM; Shea, WK | 1 |
| Berger, MR; Habs, M; Petru, E; Schmähl, D | 1 |
| Ip, MM; Schenkel, L; Sylvester, PW | 1 |
| Bryan, GT; Cohen, SM; Ertürk, E | 3 |
| Atassi, SA; Bryan, GT; Cohen, SM; Ertürk, E; Price, JM; Yoshida, O | 1 |
| Ahl, CA; Daly, JJ; Prout, GR | 1 |
| Bryan, GT; Cohen, SM; Ertürk, E; Price, JM | 1 |
| Rice, LM; Scott, KR | 1 |
2 review(s) available for thiazoles and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Recent Trends in Drug Development for the Treatment of Adenocarcinoma Breast Cancer: Thiazole, Triazole, and Thiosemicarbazone Analogues as Efficient Scaffolds.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Drug Development; Female; Humans; Thiazoles; Thiosemicarbazones; Triazoles | 2022 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
5 trial(s) available for thiazoles and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas.
Topics: Adenocarcinoma; Dasatinib; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Humans; Kaplan-Meier Estimate; Neoplasm Metastasis; Neoplastic Cells, Circulating; Pancreatic Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2013 |
Treatment-related toxicities in a phase II trial of dasatinib in patients with squamous cell carcinoma of the lung.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Dasatinib; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Protein Kinase Inhibitors; Pyrimidines; Survival Rate; Thiazoles; Treatment Outcome | 2013 |
Phase II trial of dasatinib for patients with acquired resistance to treatment with the epidermal growth factor receptor tyrosine kinase inhibitors erlotinib or gefitinib.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dasatinib; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Female; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Thiazoles; Treatment Outcome | 2011 |
Monitoring of tumour glucose metabolism by PET in a phase I study evaluating hormonal therapy in advanced pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Glucose; Hormone Antagonists; Humans; Indoleacetic Acids; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Receptors, Cholecystokinin; Thiazoles; Tomography, Emission-Computed | 2002 |
121 other study(ies) available for thiazoles and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Ziprasidone suppresses pancreatic adenocarcinoma cell proliferation by targeting GOT1 to trigger glutamine metabolism reprogramming.
Topics: Adenocarcinoma; Aspartate Aminotransferase, Cytoplasmic; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Glutamine; Humans; Pancreatic Neoplasms; Piperazines; Thiazoles | 2022 |
Evaluation of the therapeutic potential of masitinib and expression of its specific targets c-Kit, PDGFR-α, PDGFR-β, and Lyn in canine prostate cancer cell lines.
Topics: Adenocarcinoma; Animals; Benzamides; Carcinoma, Transitional Cell; Cell Line; Dog Diseases; Dogs; Male; Piperidines; Prostatic Neoplasms; Proto-Oncogene Proteins c-kit; Pyridines; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Thiazoles | 2022 |
Verification of a false positive in a two-year rat carcinogenicity study using dual control groups.
Topics: Adenocarcinoma; Administration, Oral; Animals; Benzamides; Carcinogenicity Tests; Control Groups; Endometrial Neoplasms; False Positive Reactions; Female; Rats, Inbred F344; Thiazoles; Time Factors | 2018 |
Cerebral embolism during edoxaban administration for venous thromboembolism in a patient with lung adenocarcinoma: A case report.
Topics: Adenocarcinoma; Antineoplastic Agents; Disease Progression; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Heparin; Humans; Intracranial Embolism; Lung Neoplasms; Middle Aged; Pyridines; Thiazoles; Venous Thromboembolism | 2019 |
Use of a colorimetric assay to evaluate the proliferation of canine mammary tumor cells exposed to propofol.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Cell Proliferation; Colorimetry; Coloring Agents; Dog Diseases; Dogs; Female; Hypnotics and Sedatives; Mammary Neoplasms, Animal; Propofol; Tetrazolium Salts; Thiazoles | 2019 |
Late administration of a specific COX-2 inhibitor does not treat and/or prevent progression of gastric tumors in rats submitted to duodenogastric reflux procedure.
Topics: Adenocarcinoma; Animals; Cyclooxygenase 2 Inhibitors; Disease Progression; Duodenogastric Reflux; Male; Medical Illustration; Meloxicam; Pylorus; Random Allocation; Rats; Rats, Wistar; Stomach Neoplasms; Thiazines; Thiazoles; Time Factors; Treatment Outcome | 2013 |
A convenient synthesis of lubeluzole and its enantiomer: evaluation as chemosensitizing agents on human ovarian adenocarcinoma and lung carcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Doxorubicin; Drug Synergism; Female; Humans; Lung Neoplasms; Ovarian Neoplasms; Paclitaxel; Piperidines; Stereoisomerism; Thiazoles | 2013 |
Characterization of the biological activity of a potent small molecule Hec1 inhibitor TAI-1.
Topics: Adenocarcinoma; Administration, Intravenous; Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cytoskeletal Proteins; Drug Synergism; Female; Gene Knockdown Techniques; Lung Neoplasms; Male; Mice; Mice, Nude; Niacinamide; NIMA-Related Kinases; Nuclear Proteins; Protein Serine-Threonine Kinases; Proteolysis; Retinoblastoma Protein; Thiazoles; Tumor Burden; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2014 |
Src inhibition is still a relevant target in pancreatic cancer.
Topics: Adenocarcinoma; Humans; Neoplasm Metastasis; Pancreatic Neoplasms; Pyrimidines; Thiazoles | 2014 |
ADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathway.
Topics: ADAM Proteins; Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antigens, CD; Antigens, Neoplasm; Brain Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; Dasatinib; Dexamethasone; Disease Models, Animal; Gene Knockdown Techniques; Heterografts; Humans; Lung Neoplasms; Membrane Proteins; Mice; Mice, SCID; Neoplasm Metastasis; Neoplasm Proteins; Plasminogen Activators; Pyrimidines; Thiazoles | 2014 |
C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; beta Catenin; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Gene Expression Regulation; Humans; Inhibitory Concentration 50; Lung Neoplasms; Proto-Oncogene Proteins c-myc; RNA, Small Interfering; Tetrazolium Salts; Thiazoles; Transfection | 2014 |
Hyaluronic acid decorated lipid nanocarrier for MDR modulation and CD-44 targeting in colon adenocarcinoma.
Topics: Adenocarcinoma; Camptothecin; Colonic Neoplasms; Coumarins; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Hyaluronan Receptors; Hyaluronic Acid; Irinotecan; Lipids; Nanoparticles; Thiazoles | 2015 |
Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contributes to dasatinib sensitivity via the c-Abl/Ras/ERK pathway.
Topics: Adenocarcinoma; Aged; Animals; Apoptosis; Biomarkers, Tumor; Blotting, Western; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Adhesion; Cell Movement; Cell Proliferation; Dasatinib; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Lung Neoplasms; Mice; Mice, Nude; MicroRNAs; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrimidines; ras Proteins; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
iPhos: a toolkit to streamline the alkaline phosphatase-assisted comprehensive LC-MS phosphoproteome investigation.
Topics: Adenocarcinoma; Alkaline Phosphatase; Chromatography, Liquid; Dasatinib; Humans; Immunoprecipitation; Lung Neoplasms; Phosphopeptides; Protein Kinase Inhibitors; Proteome; Proteomics; Pyrimidines; Signal Transduction; Software; Tandem Mass Spectrometry; Thiazoles; Tumor Cells, Cultured | 2014 |
Trans-Resveratrol Induces Apoptosis through ROS-Triggered Mitochondria-Dependent Pathways in A549 Human Lung Adenocarcinoma Epithelial Cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Caspase 3; Caspase 8; Cell Line, Tumor; Cell Survival; Epithelial Cells; Fluoresceins; Humans; Lung Neoplasms; Mitochondria; Reactive Oxygen Species; Resveratrol; Stilbenes; Tetrazolium Salts; Thiazoles | 2015 |
First Synthesis of Novel Aminophenyl Pyridinium-5-(hydroxybenzoyl)-hydrazonomethyl-2-oxothiazol-3-ide Derivatives and Evaluation of Their Anticancer Activities.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Pyridinium Compounds; Structure-Activity Relationship; Thiazoles | 2015 |
Effects of kinase insert domain receptor (KDR) gene silencing on the sensitivity of A549 cells to erlotinib.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Cell Proliferation; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Gene Silencing; Humans; Lung Neoplasms; RNA, Messenger; RNA, Small Interfering; Tetrazolium Salts; Thiazoles; Vascular Endothelial Growth Factor Receptor-2 | 2015 |
Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Animals; CD24 Antigen; Cell Line, Tumor; Cell Proliferation; Cell Separation; Flow Cytometry; Humans; Hyaluronan Receptors; Male; Mice; Mice, Nude; Neoplastic Stem Cells; Pancreatic Neoplasms; Tetrazolium Salts; Thiazoles; Transplantation, Heterologous | 2008 |
Sustained and efficient porphyrin generation in vivo using dendrimer conjugates of 5-ALA for photodynamic therapy.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Cell Line, Tumor; Cell Survival; Coloring Agents; Dendrimers; Dose-Response Relationship, Drug; Injections, Subcutaneous; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Molecular Structure; Molecular Weight; Photochemotherapy; Photosensitizing Agents; Porphyrins; Protoporphyrins; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles; Time Factors; Xenograft Model Antitumor Assays | 2009 |
Water extract of Rheum officinale Baill. induces apoptosis in human lung adenocarcinoma A549 and human breast cancer MCF-7 cell lines.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Humans; Lung Neoplasms; Phytotherapy; Rheum; Tetrazolium Salts; Thiazoles | 2009 |
Cytotoxicity and estrogenicity of Invisalign appliances.
Topics: Adenocarcinoma; Benzhydryl Compounds; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Coloring Agents; Dental Materials; Endocrine Disruptors; Estradiol; Estrogens, Non-Steroidal; Female; Fibroblasts; Gingiva; Humans; Materials Testing; Orthodontic Appliance Design; Phenols; Receptors, Estrogen; Sodium Chloride; Temperature; Tetrazolium Salts; Thiazoles; Time Factors; Tooth Movement Techniques | 2009 |
Dasatinib inhibits both osteoclast activation and prostate cancer PC-3-cell-induced osteoclast formation.
Topics: Adenocarcinoma; Animals; Bone Marrow Cells; Bone Neoplasms; Cell Differentiation; Cell Line, Tumor; Collagen; Dasatinib; Humans; Male; Mice; Mice, Inbred C57BL; Monocytes; Neoplasm Proteins; Osteoclasts; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyrimidines; RANK Ligand; src-Family Kinases; Thiazoles | 2009 |
Inhibition of proliferation of prostate cancer cell line, PC-3, in vitro and in vivo using (-)-gossypol.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cell Survival; Contraceptive Agents, Male; Gossypol; Humans; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Microvilli; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Tetrazolium Salts; Thiazoles; Xenograft Model Antitumor Assays | 2010 |
The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaP.
Topics: Adenocarcinoma; Androgens; Cell Cycle; Cell Line, Tumor; Cell Survival; DNA Repair; DNA, Neoplasm; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, cdc; Humans; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Radiation Tolerance; Tetrazolium Salts; Thiazoles | 2010 |
Chiral 6-hydroxymethyl-1H,3H-pyrrolo[1,2-c]thiazoles: novel antitumor DNA monoalkylating agents.
Topics: Adenocarcinoma; Antineoplastic Agents, Alkylating; Breast Neoplasms; Cell Line, Tumor; Colorectal Neoplasms; DNA; Drug Screening Assays, Antitumor; Female; Humans; Melanoma; Pyrroles; Thiazoles | 2010 |
Endostar down-regulates HIF-1 and VEGF expression and enhances the radioresponse to human lung adenocarcinoma cancer cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Cell Cycle; Cell Line, Tumor; Endostatins; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1; Lung Neoplasms; Recombinant Proteins; Tetrazolium Salts; Thiazoles; Vascular Endothelial Growth Factor A | 2012 |
Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3β and CDK1.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Camptothecin; CDC2 Protein Kinase; Cell Hypoxia; Cell Line, Tumor; Colonic Neoplasms; Drug Synergism; Fluorouracil; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Inhibitor of Apoptosis Proteins; Irinotecan; Mice; Mice, Nude; Neoplasm Proteins; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-myb; Pyrimidines; Recombinant Proteins; RNA, Small Interfering; Thiazoles; TNF-Related Apoptosis-Inducing Ligand; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2011 |
Nickel nanowires induced and reactive oxygen species mediated apoptosis in human pancreatic adenocarcinoma cells.
Topics: Adenocarcinoma; Analysis of Variance; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Fluorescent Dyes; Humans; Microscopy, Phase-Contrast; Nanotechnology; Nanowires; Nickel; Pancreatic Neoplasms; Particle Size; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles | 2011 |
Stevens-Johnson Syndrome induced by masitinib.
Topics: Adenocarcinoma; Benzamides; Colonic Neoplasms; Drug Eruptions; Humans; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyridines; Stevens-Johnson Syndrome; Thiazoles | 2012 |
Imidazo [4,5f][1,10] phenanthroline derivatives as inhibitor of c-myc gene expression in A549 cells via NF-κB pathway.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Humans; Inhibitory Concentration 50; Lung Neoplasms; Models, Chemical; Necrosis; NF-kappa B; Phenanthrolines; Proto-Oncogene Proteins c-myc; Tetrazolium Salts; Thiazoles | 2012 |
Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Biological Transport; Cell Survival; Chemistry, Pharmaceutical; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; Drug Carriers; Drug Stability; HT29 Cells; Humans; Kinetics; Lactic Acid; Meloxicam; Molecular Weight; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Solubility; Surface Properties; Thiazines; Thiazoles | 2012 |
Uptake rate of cationic mitochondrial inhibitor MKT-077 determines cellular oxygen consumption change in carcinoma cells.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Kinetics; Mammary Neoplasms, Animal; Mathematical Concepts; Mitochondria; Oxygen Consumption; Pyridines; Rats; Thiazoles | 2012 |
Inhibition of GSK-3β reverses the pro-apoptotic effect of proadifen (SKF-525A) in HT-29 colon adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle; Cell Proliferation; Colonic Neoplasms; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HT29 Cells; Humans; Proadifen; Protein Kinase Inhibitors; Thiazoles; Urea | 2012 |
Overexpression of human Argonaute2 inhibits cell and tumor growth.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Argonaute Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Mice, Nude; MicroRNAs; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Signal Transduction; Tetrazolium Salts; Thiazoles; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
Topics: 3T3 Cells; Adenocarcinoma; alpha Catenin; Animals; Antineoplastic Agents; Apoptosis; beta Catenin; Cadherins; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Cycle; Cell Cycle Proteins; Cell Division; Collagen; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Cyclooxygenase 2; Cytoskeletal Proteins; Drug Combinations; Enzyme Induction; Gene Expression Regulation, Neoplastic; Humans; Isoenzymes; Laminin; Ligands; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Membrane Proteins; Mice; Neoplasm Invasiveness; Neoplasm Proteins; Pancreatic Neoplasms; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Proteoglycans; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Trans-Activators; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2002 |
In vitro photosensitisation of a murine mammary adenocarcinoma cell line with Verteporfin.
Topics: Acridine Orange; Adenocarcinoma; Animals; Apoptosis; Coloring Agents; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Fluorescent Dyes; Light; Mammary Neoplasms, Animal; Mice; Microscopy, Fluorescence; Oxygen; Photosensitizing Agents; Porphyrins; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles; Time Factors; Tryptophan; Tumor Cells, Cultured; Verteporfin | 2002 |
Primary culture model of peroxisome proliferator-activated receptor gamma activity in prostate cancer cells.
Topics: Adenocarcinoma; Cell Division; Gene Expression Regulation, Neoplastic; Humans; Male; Phenotype; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Tumor Cells, Cultured | 2003 |
Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.
Topics: Adenocarcinoma; Antigens, Differentiation; Antigens, Neoplasm; Breast Neoplasms; Caveolin 1; Caveolin 2; Caveolins; Cell Differentiation; Cell Line; Chromans; Colonic Neoplasms; Dimerization; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Genes, Dominant; Humans; Kidney; Ligands; Macromolecular Substances; Membrane Microdomains; Neoplasm Proteins; Phenotype; Phenylacetates; Prostaglandin D2; Protein Structure, Tertiary; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; RNA, Neoplasm; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Troglitazone; Tumor Cells, Cultured | 2003 |
Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
Topics: Adenocarcinoma; Alitretinoin; Antineoplastic Agents; Apoptosis; Biliary Tract Neoplasms; Cell Differentiation; Cell Division; Chromans; Drug Screening Assays, Antitumor; Drug Synergism; Gastrointestinal Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Pancreatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Tretinoin; Troglitazone; Tumor Cells, Cultured | 2003 |
Effects of phenformin on the proliferation of human tumor cell lines.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; Culture Media; Glucose; Humans; Hypoglycemic Agents; Male; Neuroblastoma; Oncogene Protein p21(ras); Phenformin; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles | 2003 |
Sensitization to the cytotoxicity of cisplatin by transfection with nucleotide excision repair gene xeroderma pigmentosun group A antisense RNA in human lung adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Blotting, Northern; Cell Division; Cisplatin; DNA Repair; DNA-Binding Proteins; Drug Resistance, Neoplasm; Humans; Luciferases; Lung Neoplasms; Plasmids; RNA, Antisense; RNA, Messenger; Tetrazolium Salts; Thiazoles; Transfection; Tumor Cells, Cultured; Xeroderma Pigmentosum; Xeroderma Pigmentosum Group A Protein | 2003 |
Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Barrett Esophagus; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Diet; Duodenogastric Reflux; Duodenum; Epithelium; Esophageal Neoplasms; Immunoenzyme Techniques; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroso Compounds; Peroxynitrous Acid; Rats; Rats, Wistar; Reactive Nitrogen Species; Thiazoles; Thiazolidines | 2004 |
Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Northern; Cell Line, Tumor; Clusterin; Coloring Agents; Deoxycytidine; DNA; DNA Fragmentation; Dose-Response Relationship, Drug; Gemcitabine; Glycoproteins; Humans; Immunohistochemistry; In Vitro Techniques; Lung Neoplasms; Mice; Molecular Chaperones; Nucleotides; Oligonucleotide Array Sequence Analysis; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Double-Stranded; RNA, Small Interfering; Tetrazolium Salts; Thiazoles; Time Factors | 2004 |
Alteration of cellular phenotype and responses to oxidative stress by manganese superoxide dismutase and a superoxide dismutase mimic in RWPE-2 human prostate adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; Antioxidants; Ascorbic Acid; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA, Complementary; Dose-Response Relationship, Drug; Glutathione; Glutathione Peroxidase; Humans; Male; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxygen; Phenotype; Plasmids; Prostatic Neoplasms; Rats; Sodium Selenite; Superoxide Dismutase; Tetrazolium Salts; Thiazoles; Transfection | 2004 |
Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy.
Topics: Adenocarcinoma; Adenoviridae; Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cholecalciferol; Endothelial Cells; Genetic Therapy; Genetic Vectors; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; Microscopy, Confocal; Neoplasm Metastasis; Neovascularization, Pathologic; Osteocalcin; Promoter Regions, Genetic; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles; Transplantation, Heterologous; Vascular Endothelial Growth Factor Receptor-2 | 2005 |
Effect of natural and synthetic estrogens on a549 lung cancer cells: correlation of chemical structures with cytotoxic effects.
Topics: Adenocarcinoma; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Replication; DNA, Neoplasm; Dose-Response Relationship, Drug; Estradiol Congeners; Estrogens, Non-Steroidal; Fluorescence; Humans; Lung Neoplasms; Phenols; Reproducibility of Results; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles | 2005 |
HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Biomarkers; Breast Neoplasms; Camptothecin; Carcinoma; Colonic Neoplasms; Coloring Agents; Drug Interactions; Drug Resistance, Neoplasm; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Gene Expression Profiling; Humans; Lung Neoplasms; Paclitaxel; Potassium Channels, Voltage-Gated; Tetrazolium Salts; Thiazoles; Transfection; Vincristine | 2005 |
IB1/JIP-1 controls JNK activation and increased during prostatic LNCaP cells neuroendocrine differentiation.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenoviridae; Animals; Apoptosis; Benzimidazoles; Blotting, Northern; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Densitometry; Disease Progression; Enzyme Activation; Epithelial Cells; Fenretinide; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; JNK Mitogen-Activated Protein Kinases; Luciferases; Male; MAP Kinase Kinase 4; Microscopy, Fluorescence; Mitogen-Activated Protein Kinase Kinases; Neoplasms; Neurons; Neurosecretory Systems; Phenotype; Plasmids; Prostate; Prostatic Neoplasms; Rats; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA; Synaptophysin; Tetrazolium Salts; Thiazoles; Tissue Distribution; Transcription Factors; Transcription, Genetic; Up-Regulation | 2005 |
Theophylline stimulates cAMP-mediated signaling associated with growth regulation in human cells from pulmonary adenocarcinoma and small airway epithelia.
Topics: Adenocarcinoma; Animals; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Colforsin; Cricetinae; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Epithelial Cells; Humans; Immunoassay; Lung Neoplasms; MAP Kinase Signaling System; Muscle, Smooth; Phosphodiesterase Inhibitors; Phosphorylation; Signal Transduction; Tetrazolium Salts; Theophylline; Thiazoles; Time Factors; Trachea | 2005 |
Effects of anthocyanidin on the inhibition of proliferation and induction of apoptosis in human gastric adenocarcinoma cells.
Topics: Adenocarcinoma; Anthocyanins; Apoptosis; Blotting, Western; Caspase 3; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromatography, High Pressure Liquid; Flow Cytometry; Humans; Membrane Potentials; Microscopy, Phase-Contrast; Mitochondria; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Stomach Neoplasms; Tetrazolium Salts; Thiazoles | 2005 |
Characterization of the activities of actin-affecting drugs on tumor cell migration.
Topics: Actins; Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cytochalasin D; Cytoskeleton; Depsipeptides; Humans; Inhibitory Concentration 50; Lung Neoplasms; Neoplasm Invasiveness; Statistics, Nonparametric; Thiazoles; Thiazolidines | 2006 |
Thioproline prevents carcinogenesis in the remnant stomach induced by duodenal reflux.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Duodenum; Gastric Mucosa; Male; Models, Anatomic; Nitrites; Rats; Rats, Wistar; Stomach Neoplasms; Thiazoles; Thiazolidines | 2006 |
Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Dasatinib; Disease Models, Animal; Disease Progression; Humans; Interleukin-8; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neovascularization, Pathologic; Pancreatic Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-yes; Proto-Oncogene Proteins pp60(c-src); Pyrimidines; RNA, Small Interfering; src-Family Kinases; Thiazoles; Vascular Endothelial Growth Factor A | 2006 |
Growth-inhibitory action of melatonin and thiazolidinedione derivative CGP 52608 on murine 16/C breast cancer cells.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Melatonin; Methotrexate; Mice; Nuclear Receptor Subfamily 1, Group F, Member 2; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Statistics, Nonparametric; Thiazoles; Thiosemicarbazones | 2006 |
The neurotrophic factor artemin promotes pancreatic cancer invasion.
Topics: Adenocarcinoma; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Coloring Agents; Glial Cell Line-Derived Neurotrophic Factor Receptors; Humans; Hypertrophy; Immunohistochemistry; Neoplasm Invasiveness; Nerve Growth Factors; Nerve Regeneration; Nerve Tissue Proteins; Neurons; Pain; Pancreas; Pancreatic Neoplasms; Polymerase Chain Reaction; Prospective Studies; Tetrazolium Salts; Thiazoles | 2006 |
Pulmonary fibroblasts stimulate the proliferation of cell lines from human lung adenocarcinomas.
Topics: Adenocarcinoma; Amphiregulin; Animals; Antibodies, Blocking; Cell Line, Tumor; Cell Proliferation; Coculture Techniques; Culture Media, Conditioned; Cyclin D1; Cyclin E; EGF Family of Proteins; Enzyme Activation; Epidermal Growth Factor; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Glycoproteins; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Lung; Lung Neoplasms; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Thiazoles; Transforming Growth Factor alpha | 2006 |
Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.
Topics: Adenocarcinoma; Animals; Apoptosis; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Male; Mice; Mice, Nude; Middle Aged; NF-kappa B; Pancreatic Neoplasms; Structure-Activity Relationship; Survival Rate; Thiazoles; Transplantation, Heterologous; Urea; Xenograft Model Antitumor Assays | 2006 |
Novel structural motifs consisting of chiral thiazolines: synthesis, molecular recognition, and anticancer activity.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Survival; Colorectal Neoplasms; Humans; Macrocyclic Compounds; Male; Molecular Structure; Pancreatic Neoplasms; Prostatic Neoplasms; Thiazoles; Tumor Cells, Cultured | 2007 |
The anti-cancer effect of COX-2 inhibitors on gastric cancer cells.
Topics: Adenocarcinoma; Apoptosis; Celecoxib; Cell Cycle; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; Dinoprostone; Humans; Microscopy, Fluorescence; Pyrazoles; Stomach Neoplasms; Sulfonamides; Tetrazolium Salts; Thiazoles | 2007 |
Bcl-XL small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; bcl-X Protein; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Lung Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Tetrazolium Salts; Thiazoles; Transfection | 2007 |
Comparison of the antivascular and cytotoxic activities of TZT-1027 (Soblidotin) with those of other anticancer agents.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Membrane Permeability; Cell Survival; Colonic Neoplasms; Dextrans; Diffusion; Endothelial Cells; Endothelium, Vascular; Female; Fluorescein-5-isothiocyanate; Humans; Indicators and Reagents; Mice; Mice, Inbred BALB C; Oligopeptides; Tetrazolium Salts; Thiazoles; Umbilical Veins | 2007 |
Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells.
Topics: Adenocarcinoma; Apoptosis; Cell Line, Tumor; Cell Survival; Ceramides; Down-Regulation; Enzyme Inhibitors; Humans; Male; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Sphingosine; Thiazoles | 2007 |
Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCEL), a multi-targeted kinase inhibitor.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biomarkers; Cell Division; Dasatinib; Drug Monitoring; Female; Humans; Leukocytes, Mononuclear; Male; Mice; Mice, Nude; Neoplasm Proteins; Phosphoproteins; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Specific Pathogen-Free Organisms; src-Family Kinases; Substrate Specificity; Thiazoles; Xenograft Model Antitumor Assays | 2008 |
Frequent overexpression of Aurora Kinase A in upper gastrointestinal adenocarcinomas correlates with potent antiapoptotic functions.
Topics: Adenocarcinoma; Apoptosis; Aurora Kinase A; Aurora Kinases; Biomarkers, Tumor; Blotting, Western; Camptothecin; Coloring Agents; Cytochromes c; Enzyme Inhibitors; Esophageal Neoplasms; Flow Cytometry; Gene Expression Regulation, Enzymologic; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Luciferases; Luminescent Agents; Polymerase Chain Reaction; Protein Array Analysis; Protein Serine-Threonine Kinases; Stomach Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Suppressor Protein p53 | 2008 |
Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Cycle; Cell Division; Cell Line, Tumor; DNA Fragmentation; DNA Primers; Esophageal Neoplasms; Flavones; Flavonols; G2 Phase; Humans; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Tetrazolium Salts; Thiazoles | 2008 |
Sodium salicylate switches glucose depletion-induced necrosis to autophagy and inhibits high mobility group box protein 1 release in A549 lung adenocarcinoma cells.
Topics: Adenocarcinoma; Anti-Inflammatory Agents; Autophagy; Benzimidazoles; Cell Line, Tumor; Cyclooxygenase Inhibitors; Gene Expression Regulation, Neoplastic; Glucose; HMGB1 Protein; Humans; Lung Neoplasms; Necrosis; Sodium Salicylate; Superoxide Dismutase; Tetrazolium Salts; Thiazoles | 2008 |
Inhibition of tumor cell growth by a human B-cell line.
Topics: Adenocarcinoma; Antigens, CD20; B-Lymphocytes; Breast Neoplasms; Cell Survival; Coloring Agents; Herpesvirus 4, Human; Humans; Immunity, Cellular; Killer Cells, Lymphokine-Activated; Leukemia, Hairy Cell; Lymphocytes, Tumor-Infiltrating; Polymerase Chain Reaction; Receptors, Antigen, B-Cell; Receptors, Interleukin-2; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1994 |
The identification of drug resistance in ovarian cancer and breast cancer: application of the MTT assay.
Topics: Adenocarcinoma; Breast Neoplasms; Colorimetry; Coloring Agents; Drug Resistance; Drug Screening Assays, Antitumor; Feasibility Studies; Female; Humans; Neoplasm Staging; Ovarian Neoplasms; Pilot Projects; Predictive Value of Tests; Prognosis; Tetrazolium Salts; Thiazoles | 1994 |
Characterization of the differentiation of human colorectal cancer cell lines by means of Voronoi diagrams.
Topics: Adenocarcinoma; Analog-Digital Conversion; Animals; Blood Physiological Phenomena; Cattle; Cell Death; Cell Differentiation; Cell Division; Cell Nucleus; Clone Cells; Colorectal Neoplasms; Colorimetry; Culture Media; Culture Media, Serum-Free; Humans; Image Processing, Computer-Assisted; Models, Theoretical; S Phase; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1993 |
The modulation by L-leucovorin of 5-fluorouracil antitumor activity on human colon carcinoma cells in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Fluorouracil; Humans; Infusions, Parenteral; Leucovorin; Male; Mice; Mice, Inbred Strains; Mice, Nude; Models, Biological; Neoplasm Transplantation; Tetrazolium Salts; Thiazoles; Thymidylate Synthase; Tumor Cells, Cultured | 1993 |
[In vitro comparison of podophyllotoxin analogues; etoposide, teniposide and NK 611 using human lung cancer cell lines].
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Division; Drug Resistance; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Podophyllotoxin; Teniposide; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1993 |
Anti-proliferative effects of the arotinoid Ro 40-8757 on human cancer cell lines in vitro.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Division; Cell Survival; Colorectal Neoplasms; Drug Screening Assays, Antitumor; Humans; Kinetics; Lung Neoplasms; Morpholines; Neoplasms; Receptors, Estrogen; Retinoids; Tetrazolium Salts; Thiazoles; Tretinoin; Tumor Cells, Cultured | 1993 |
Novel doxorubicin-monoclonal anti-carcinoembryonic antigen antibody immunoconjugate activity in vitro.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Carcinoembryonic Antigen; Cell Survival; Colonic Neoplasms; Doxorubicin; Humans; Immunotoxins; Sulfhydryl Reagents; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1995 |
In vitro cytotoxicity and immunomodulating property of Rhaphidophora korthalsii.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Division; Colonic Neoplasms; Coloring Agents; Concanavalin A; Dose-Response Relationship, Drug; Female; Humans; Leukemia; Leukemia P388; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Nasopharyngeal Neoplasms; Plant Extracts; Plant Lectins; Plants, Medicinal; Spleen; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Water | 1996 |
Evaluation of antiherpetic compounds using a gastric cancer cell line: pronounced activity of BVDU against herpes simplex virus replication.
Topics: Adenocarcinoma; Antiviral Agents; Bromodeoxyuridine; Colorimetry; Coloring Agents; Drug Evaluation, Preclinical; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Stomach Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Virus Replication | 1996 |
Increased L-arginine transport in a nitric oxide-producing metastatic colon cancer cell line.
Topics: Adenocarcinoma; Arginine; Biological Transport; Cell Division; Cell Membrane; Colonic Neoplasms; Coloring Agents; Dexamethasone; Glucocorticoids; Humans; Hydrogen-Ion Concentration; Kinetics; Lymphatic Metastasis; Nitric Oxide; Sodium; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Up-Regulation | 1996 |
Modulation of sensitivity to cis-diamminedichloroplatinum (II) by thromboxane A2 receptor antagonists in non-small-cell lung cancer cell lines.
Topics: Adenocarcinoma; Antineoplastic Agents; Benzoquinones; Bridged Bicyclo Compounds; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Fatty Acids, Monounsaturated; Heptanoic Acids; Humans; Lung Neoplasms; Prostaglandin Antagonists; Receptors, Thromboxane; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1996 |
Differential expression of apoptosis receptors on diffuse and intestinal type stomach carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Apoptosis; Blotting, Western; Coloring Agents; Electrophoresis; fas Receptor; Female; Frozen Sections; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Male; Middle Aged; Receptors, Cell Surface; Stomach Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Suppressor Protein p53 | 1997 |
Effect of CPT-11 in combination with other anticancer agents in lung cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cell Survival; Drug Interactions; Drug Screening Assays, Antitumor; Humans; Irinotecan; Lung Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1997 |
Indomethacin enhances the cytotoxicity of VCR and ADR in human pulmonary adenocarcinoma cells.
Topics: Adenocarcinoma; Adjuvants, Pharmaceutic; Coloring Agents; Doxorubicin; Drug Combinations; Drug Screening Assays, Antitumor; Etoposide; Humans; Indomethacin; Lung Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Vincristine | 1997 |
Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice.
Topics: Adenocarcinoma; Animals; Apoptosis; Breast; Breast Neoplasms; Cell Differentiation; Chromans; Genes, bcl-2; Humans; Hypoglycemic Agents; Ligands; Mice; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Thiazoles; Thiazolidinediones; Transcription Factors; Transfection; Troglitazone; Tumor Cells, Cultured | 1998 |
The clinical relevance of chemosensitivity testing in ovarian cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Cisplatin; Drug Resistance, Neoplasm; Female; Humans; Ovarian Neoplasms; Sensitivity and Specificity; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1998 |
Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice.
Topics: Adenocarcinoma; Animals; beta Catenin; Chromans; Colorectal Neoplasms; Cyclooxygenase 2; Cytoskeletal Proteins; HT29 Cells; Humans; Isoenzymes; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Prostaglandin-Endoperoxide Synthases; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Trans-Activators; Transcription Factors; Troglitazone | 1998 |
Differentiation and reversal of malignant changes in colon cancer through PPARgamma.
Topics: Adenocarcinoma; Animals; Cell Differentiation; Cell Division; Chromans; Colonic Neoplasms; Gene Expression; Humans; Ligands; Mice; Mice, Nude; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone; Tumor Cells, Cultured | 1998 |
Activators of the nuclear receptor PPARgamma enhance colon polyp formation.
Topics: Adenocarcinoma; Adenomatous Polyposis Coli; Animals; Chromans; Diet; Humans; Ligands; Mice; Mice, Inbred C57BL; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 1998 |
Therapeutic effect of clarithromycin on a transplanted tumor in rats.
Topics: Adenocarcinoma; Animals; Chromium Radioisotopes; Clarithromycin; Collagenases; Coloring Agents; Cytotoxicity, Immunologic; Humans; Interleukin-6; Male; Mammary Neoplasms, Experimental; Matrix Metalloproteinase 9; Neoplasm Transplantation; Rats; Rats, Inbred F344; Spleen; Tetrazolium Salts; Thiazoles; Transforming Growth Factor beta; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1999 |
Effect of vesnarinone in combination with anti-cancer drugs on lung cancer cell lines.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cell Division; Cisplatin; Coloring Agents; Deoxycytidine; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Flow Cytometry; Gemcitabine; Humans; Lung Neoplasms; Pyrazines; Quinolines; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1999 |
The oncostatic action of melatonin in an ovarian carcinoma cell line.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Calcium; Cell Count; Cell Cycle; Cell Division; DNA; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Melatonin; Ovarian Neoplasms; Signal Transduction; Thiazoles; Thiosemicarbazones; Trypan Blue; Tumor Cells, Cultured | 1999 |
In vitro augmentation of antitumor effect in combination with CPT-11 and CDDP for human colorectal cancer.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Colonic Neoplasms; Coloring Agents; Drug Synergism; Female; Humans; Irinotecan; Male; Middle Aged; Mitomycin; Rectal Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2000 |
Effect of the specific cyclooxygenase-2 inhibitor meloxicam on tumour growth and cachexia in a murine model.
Topics: Adenocarcinoma; Animals; Body Weight; Cachexia; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Isoenzymes; Male; Meloxicam; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Prostaglandin-Endoperoxide Synthases; Thiazines; Thiazoles; Time Factors | 2000 |
Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
Topics: Adenocarcinoma; Androgen Antagonists; Antineoplastic Agents; Blotting, Western; Chromans; Dihydrotestosterone; Down-Regulation; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Ligands; Male; Middle Aged; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Receptors, Cytoplasmic and Nuclear; Response Elements; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Troglitazone | 2000 |
Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Blotting, Northern; Cell Cycle Proteins; Cell Division; Chromans; Cyclin-Dependent Kinase Inhibitor p27; G1 Phase; Growth Inhibitors; Humans; Immunohistochemistry; Luciferases; Microtubule-Associated Proteins; Oligonucleotides, Antisense; Pancreatic Neoplasms; Peroxisome Proliferators; Receptors, Cytoplasmic and Nuclear; Response Elements; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2000 |
PPARgamma ligand (thiazolidinedione) induces growth arrest and differentiation markers of human pancreatic cancer cells.
Topics: Adenocarcinoma; Antigens, Differentiation; Antigens, Neoplasm; Antineoplastic Agents; Blotting, Western; Carcinoma; Cell Cycle; Cell Differentiation; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Gene Expression Regulation, Neoplastic; Growth Inhibitors; Humans; Ligands; Neoplasm Proteins; Pancreatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2000 |
Sensitivity of human pancreatic adenocarcinoma tumor lines to chemotherapy, radiotherapy, and hyperthermia.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line; Coloring Agents; Drug Screening Assays, Antitumor; Humans; Hyperthermia, Induced; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2000 |
Prodigiosin-induced apoptosis in human colon cancer cells.
Topics: 3T3 Cells; Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Apoptosis; Benzimidazoles; Caspases; Cell Survival; Colonic Neoplasms; DNA; Drug Screening Assays, Antitumor; Enzyme Activation; Fluorescent Dyes; Humans; Mice; Prodigiosin; Serratia marcescens; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2001 |
Neoadjuvant chemotherapy in inoperable, locally advanced, and inflammatory breast carcinoma: a pilot study of MTT assay in vitro and outcome analysis of 10 patients.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Coloring Agents; Drug Screening Assays, Antitumor; Humans; Middle Aged; Neoplasm Staging; Pilot Projects; Tetrazolium Salts; Thiazoles | 2001 |
Effect of PPAR activators on cytokine-stimulated cyclooxygenase-2 expression in human colorectal carcinoma cells.
Topics: Adenocarcinoma; Colorectal Neoplasms; Cyclooxygenase 2; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Isoenzymes; Ligands; Membrane Proteins; Models, Biological; Prostaglandin-Endoperoxide Synthases; Pyrimidines; Receptor Cross-Talk; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Necrosis Factor-alpha | 2001 |
p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents.
Topics: Adenocarcinoma; Alleles; Amino Acid Chloromethyl Ketones; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Benzothiazoles; Butyrates; Cisplatin; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine Proteinase Inhibitors; Demecolcine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Intracellular Membranes; Membrane Potentials; Mitochondria; Neoplasm Proteins; Recombination, Genetic; Resveratrol; Stilbenes; Thiazoles; Toluene; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |
PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Chromans; DNA Primers; Esophageal Neoplasms; Flow Cytometry; Humans; Immunologic Factors; Ligands; Ornithine Decarboxylase; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Thiazoles; Thiazolidinediones; Thymidine; Transcription Factors; Troglitazone; Tumor Cells, Cultured | 2001 |
Inhibition of monocyte chemoattractant protein-1 expression in cytokine-treated human lung epithelial cells by thiazolidinedione.
Topics: Adenocarcinoma; Chemokine CCL2; Gene Expression; Humans; Interleukin-1; Lung; Lung Neoplasms; Respiratory Mucosa; RNA, Messenger; Thiazoles; Thiazolidinediones; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2001 |
Chemosensitivity testing predicts survival in ovarian cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cell Survival; Coloring Agents; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Middle Aged; Ovarian Neoplasms; Predictive Value of Tests; Retrospective Studies; Survival Rate; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2001 |
Growth inhibition and differentiation of pancreatic cancer cell lines by PPAR gamma ligand troglitazone.
Topics: Adenocarcinoma; Cell Differentiation; Cell Division; Chromans; Dose-Response Relationship, Drug; Flow Cytometry; Ligands; Pancreatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone; Tumor Cells, Cultured | 2002 |
Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung.
Topics: Adenocarcinoma; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Synergism; Gelsolin; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Ligands; Lung Neoplasms; Phenylbutyrates; Receptors, Cytoplasmic and Nuclear; Repressor Proteins; RNA; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Cells, Cultured | 2002 |
The mode of action of the antitumour agent GP 48,989 in the rat.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Castration; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Ovary; Random Allocation; Rats; Receptors, Estrogen; Tamoxifen; Thiazoles; Time Factors; Transplantation, Homologous; Uterus | 1979 |
MTT assays allow quick and reliable measurement of the response of human tumour cells to photodynamic therapy.
Topics: Adenocarcinoma; Breast Neoplasms; Chromatography, High Pressure Liquid; Colonic Neoplasms; Female; Hematoporphyrin Derivative; Hematoporphyrins; Humans; Photochemotherapy; Radiation-Sensitizing Agents; Sensitivity and Specificity; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1992 |
Application of the chemiluminescent assay to cytotoxicity test: detection of menadione-catalyzed H2O2 production by viable cells.
Topics: 3T3 Cells; Adenocarcinoma; Animals; Antineoplastic Agents; Cell Count; Cell Line; Cell Survival; Coloring Agents; Humans; Hydrogen Peroxide; Indicators and Reagents; Luminescent Measurements; Male; Mice; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles; Tomatine; Tumor Cells, Cultured; Vitamin K | 1992 |
[Estimating doses of anti-cancer agents in sensitivity tests in vitro].
Topics: Adenocarcinoma; Antineoplastic Agents; Carboplatin; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Humans; Mitomycin; Tetrazolium Salts; Thiazoles; Tumor Stem Cell Assay | 1992 |
Activity of two platinum-linked phosphonic acids against autochthonous rat colorectal cancer as well as in two human colon-cancer cell lines.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; Colorectal Neoplasms; Drug Screening Assays, Antitumor; Humans; Male; Organophosphonates; Organophosphorus Compounds; Organoplatinum Compounds; Rats; Rats, Inbred Lew; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1992 |
Expression of MDR1 and glutathione S transferase-pi genes and chemosensitivities in human gastrointestinal cancer.
Topics: Adenocarcinoma; Blotting, Northern; Cell Line; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Resistance; Glutathione Transferase; Humans; Nucleic Acid Hybridization; RNA, Messenger; Stomach Neoplasms; Tetrazolium Salts; Thiazoles | 1992 |
Increased drug resistance of cultured human cancer cell lines in three-dimensional cellular growth assay using collagen gel matrix.
Topics: Adenocarcinoma; Antineoplastic Agents; Cisplatin; Collagen; Colonic Neoplasms; Culture Media; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Mitomycin; Stomach Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1992 |
Quantitative structure-activity relationships of antitumor guanidinothiazolecarboxamides with survival enhancement for therapy in the 3LL Lewis lung carcinoma model.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Female; Guanidines; Lung Neoplasms; Mice; Models, Biological; Neoplasms, Experimental; Structure-Activity Relationship; Thiazoles | 1991 |
Short-term primary culture of rat prostate tumor epithelial cells on reconstituted basement membrane as a useful in vitro model to assess drug action on prostatic cancer: efficacy of the thiazolidinedione derivative CGP 19984.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Basement Membrane; Disease Models, Animal; Epithelium; Male; Prostatic Neoplasms; Rats; Thiazoles; Thiazolidines; Tumor Cells, Cultured | 1989 |
Influence of the application mode of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide on the localization of its carcinogenic expression in female NMRI-mice.
Topics: Adenocarcinoma; Administration, Oral; Animals; Carcinoma, Squamous Cell; FANFT; Female; Mice; Mice, Inbred Strains; Papilloma; Stomach Neoplasms; Thiazoles; Urinary Bladder Neoplasms | 1986 |
Antitumor efficacy in rats of CGP 19984, a thiazolidinedione derivative that inhibits luteinizing hormone secretion.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Castration; Corticosterone; Female; Luteinizing Hormone; Male; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Prolactin; Prostatic Neoplasms; Rats; Rats, Inbred F344; Testosterone; Thiazoles; Thiazolidines | 1986 |
Carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl] acetamide in female rats.
Topics: Acetamides; Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adenofibroma; Animals; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemical Phenomena; Chemistry; Female; Fibroma; Fibrosarcoma; Intestinal Neoplasms; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma, Non-Hodgkin; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Nitrofurans; Rats; Salivary Gland Neoplasms; Skin Neoplasms; Splenic Neoplasms; Thiazoles; Time Factors; Transplantation, Homologous | 1970 |
Carcinogenicity of formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]-hydrazide in Swiss mice.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Animals; Body Weight; Carcinogens; Carcinoma, Squamous Cell; Diet; Female; Formates; Hydrazines; Leukemia, Experimental; Liver Neoplasms; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Nitrofurans; Skin Neoplasms; Stomach Neoplasms; Thiazoles; Uterine Neoplasms | 1970 |
Comparative urinary and gallbladder carcinogenicity of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide and N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide in the dog.
Topics: Acetamides; Adenocarcinoma; Adenocarcinoma, Scirrhous; Adenofibroma; Animals; Carcinogens; Carcinoma, Transitional Cell; Dogs; Female; Formamides; Gallbladder; Gallbladder Neoplasms; Kidney Neoplasms; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Nitrofurans; Thiazoles; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Urogenital System | 1970 |
Demonstration of specific antigen in N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide induced rat bladder tumor.
Topics: Adenocarcinoma; Animals; Antigens, Neoplasm; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Culture Techniques; Cytotoxicity Tests, Immunologic; Female; Formamides; Histocompatibility Antigens; Immunodiffusion; Isoenzymes; Karyotyping; L-Lactate Dehydrogenase; Neoplasm Transplantation; Neoplasms, Experimental; Nitrofurans; Parabiosis; Rats; Thiazoles; Urinary Bladder Neoplasms | 1973 |
Induction, histogenesis, and isotransplanta bility of renal tumors induced by formic acid 2-[4-(5-nitro-2-furyl)-2-triazolyl]-hydrazide in rats.
Topics: Adenocarcinoma; Animals; Carcinogens; Carcinoma, Transitional Cell; Female; Formates; Hydrazines; Kidney Neoplasms; Male; Neoplasm Transplantation; Neoplasms, Experimental; Nitrofurans; Rats; Thiazoles; Transplantation, Homologous | 1970 |
Comparative carcinogenicity in the rat of 2-hydrazinothiazoles with nitrofuryl, nitrophenyl, or aminophenyl substituents in the 4-position.
Topics: Adenocarcinoma; Adenofibroma; Animals; Body Weight; Carcinogens; Chemical Phenomena; Chemistry; Diet; Female; Hydrazines; Lung Neoplasms; Lymphoma, Non-Hodgkin; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Neoplasms, Experimental; Nitrobenzenes; Nitrofurans; Rats; Salivary Gland Neoplasms; Splenic Neoplasms; Thiazoles | 1970 |
Imidothiazoles.
Topics: Acids; Adenocarcinoma; Animals; Carcinoma; Culture Techniques; Imides; Leukemia; Leukemia L1210; Melanoma; Methods; Mice; Sarcoma 180; Thiazoles | 1968 |